ANTIDIABETICS AND NEOMYCIN
Neomycin alone can reduce postprandial blood glucose levels, and may enhance the reduction in postprandial glucose levels associated with acarbose. Neomycin also appears to increase the unpleasant gastrointestinal adverse effects (flatulence, cramps and diarrhoea) of acarbose.
The manufacturers suggest that if these adverse effects are severe the dosage of acarbose should be reduced.
The manufacturers suggest that if these adverse effects are severe the dosage of acarbose should be reduced.